Efficacy of targeted therapy in patients with HER2‐positive non‐small cell lung cancer: A systematic review and meta‐analysis

Anti‐human epidermal growth factor receptor 2 (HER2) therapy is an effective treatment for HER2‐positive gastric and breast malignancies. However, the efficacy of HER2‐targeted therapy in non‐small cell lung cancer (NSCLC) patients with HER2 alterations remains controversial. We searched studies on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hong‐Xia, Zhuo, Kai‐Quan, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302639/
https://www.ncbi.nlm.nih.gov/pubmed/34820879
http://dx.doi.org/10.1111/bcp.15155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302639/
https://www.ncbi.nlm.nih.gov/pubmed/34820879
http://dx.doi.org/10.1111/bcp.15155

Ejemplares similares